About

David Shum is a prominent researcher whose work sits at the intersection of aging, dementia care, and assistive technology. He is perhaps best known for leading a landmark cluster-randomized controlled trial investigating the therapeutic effects of PARO, a robotic seal, on the emotional and behavioral symptoms of dementia in long-term care settings. This foundational 2017 study has garnered 278 citations and sparked a suite of follow-on investigations examining PARO's influence on agitation, motor activity, sleep patterns, psychotropic medication use, and cost-effectiveness — collectively representing some of the most rigorous evidence in the field of socially assistive robotics. Shum's research has demonstrated that non-pharmacological, technology-driven interventions can offer meaningful relief for dementia symptoms while potentially reducing reliance on costly medications. His 2018 cost-effectiveness analysis (111 citations) and sleep-pattern study (90 citations) underscore both the clinical and economic significance of his contributions. More recently, Shum has broadened his focus to technology-based cognitive interventions for older adults more generally, as reflected in his 2022 review paper. With hundreds of citations across his dementia-technology portfolio, his work has meaningfully shaped how researchers, clinicians, and policymakers think about innovative, compassionate care for aging populations.

Research Focus

Key Achievements

7
H-Index
9
Papers
735
Total Citations
82
Avg Citations/Paper
🏆 Most Cited Paper
Use of a Robotic Seal as a Therapeutic Tool to Improve Dementia Symptoms: A Cluster-Randomized Controlled Trial
278 citations · 2017
📈 Most Prolific Year: 2017 (3 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Griffith University, Institute of Psychology, Chinese Academy of Sciences, Hong Kong Polytechnic University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago